CVR number 28712669
Industry 86.9010 Other human health activities

JORDEMODER.DK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.4% 1.7% 5.9% 4.6% 5.4%  
Credit score (0-100)  65 73 38 45 41  
Credit rating  BBB A BBB BBB BBB  
Credit limit (kDKK)  0.0 4.1 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  1,411 1,705 1,379 755 808  
EBITDA  266 625 25.9 87.4 160  
EBIT  195 555 -29.6 82.9 51.8  
Pre-tax profit (PTP)  211.5 598.3 43.9 168.7 49.1  
Net earnings  159.9 464.8 33.8 131.1 37.8  
Pre-tax profit without non-rec. items  212 598 43.9 169 49.1  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  178 305 39.6 35.1 30.6  
Shareholders equity total  2,033 2,498 2,332 263 300  
Interest-bearing liabilities  0.0 13.8 374 864 68.0  
Balance sheet total (assets)  2,439 3,271 3,223 1,516 831  
Net Debt  -1,032 -885 369 707 -29.4  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,411 1,705 1,379 755 808  
Gross profit growth  4.0% 20.8% -19.1% -45.2% 7.0%  
Employees  3 3 3 2 2  
Employee growth %  0.0% 0.0% 0.0% -33.3% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,439 3,271 3,223 1,516 831  
Balance sheet change%  -1.3% 34.1% -1.5% -53.0% -45.2%  
Added value  265.5 625.0 25.9 138.4 159.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  54 56 -126 -204 -113  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 -1.0 1.0 2.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  13.8% 32.5% -2.1% 11.0% 6.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.5% 21.1% 1.6% 8.3% 4.4%  
ROI %  11.8% 26.3% 1.9% 10.0% 6.7%  
ROE %  8.2% 20.5% 1.4% 10.1% 13.4%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  83.4% 76.4% 72.3% 17.3% 36.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -388.6% -141.6% 1,426.8% 808.8% -18.4%  
Gearing %  0.0% 0.6% 16.1% 329.0% 22.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 74.2% 3.7% 4.7% 0.6%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  5.9 3.8 3.7 1.1 1.3  
Current Ratio  5.9 3.8 3.7 1.1 1.3  
Cash and cash equivalent  1,031.8 898.6 5.0 157.1 97.4  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,879.0 2,090.8 2,241.9 150.5 143.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  89 208 9 69 80  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  89 208 9 44 80  
EBIT / employee  65 185 -10 41 26  
Net earnings / employee  53 155 11 66 19